Deals channel feed

Up­dat­ed: No­vo makes an­oth­er car­diometa­bol­ic deal fo­cused on oral med­i­cines

4 weeks ago
Startups

BMS’ Rayze­Bio inks ra­dio­phar­ma deal in prostate can­cer for $350M up­front

4 weeks ago
R&D

At a cross­roads, biotechs are pass­ing on re­verse merg­ers in 2025

Last month
Financing

Anne Wo­j­ci­c­ki and Re­gen­eron set to duke it out in restart­ed 23andMe auc­tion

Last month
Pharma

Lil­ly makes a move for long-act­ing in­cretins in tech deal with Swedish biotech

Last month
R&D

Agenus quick­ly ex­its CD­MO busi­ness by sell­ing as­sets to Zy­dus for $75M up­front

Last month
Manufacturing

BioN­Tech presents im­pres­sive ear­ly da­ta for PD-L1xVEGF in mesothe­lioma

Last month
R&D

Pyx Health buys Farm­boxRx to reach more Med­ic­aid and Medicare mem­bers

Last month
Health Tech

Re­gen­eron makes $80M obe­si­ty deal with Han­soh

Last month
R&D
China

Sanofi to snap up Blue­print Med­i­cines and mas­to­cy­to­sis drug Ay­vak­it for $9.1B

Last month
R&D

Bris­tol My­ers bets $1.5B on BioN­Tech's PD-L1xVEGF from Bio­theus

Last month
China
Pharma

As a chal­leng­ing first half nears a close, bio­phar­ma un­cer­tain­ty per­sists

Last month
Financing
Pharma

Astel­las li­cens­es Claudin18.2 ADC from Chi­na’s Evo­point Bio­sciences

Last month
China

Post-Hoc Live: Is biotech sen­ti­ment re­al­ly as bad as it seems? 

Last month
Financing
Editor's note

No­var­tis won bid­ding war for kid­ney drug as Reg­u­lus' top three ex­ecs ex­pect to make over $100M com­bined

Last month

Lil­ly to buy non-opi­oid pain biotech SiteOne for up to $1B

Last month
Pharma

Bio­gen taps City Ther­a­peu­tics in RNAi deal worth up to $1B

Last month
Startups
Pharma

Black­stone's GRIN inks epilep­sy li­cens­ing deal with An­geli­ni, clos­es $140M Se­ries D

Last month
Pharma

TCG's R&D ven­ture team makes a T cell en­gager deal with Shang­hai biotech

Last month
Startups
China

Up­dat­ed: Hinge Health jumped 18% on its first day as the dig­i­tal health IPO mar­ket reawak­ens

Last month
Financing
Health Tech

Sanofi makes $470M move for Vig­il's Alzheimer's drug, while an­oth­er as­set re­turns to Am­gen

Last month
Pharma

BioN­Tech in­vests £1B in grow­ing UK foot­print un­der ex­pand­ed pact with gov­ern­ment

Last month
R&D

Genen­tech ex­pands deal with mol­e­c­u­lar glue biotech Ori­o­n­is for $105M up­front

Last month
R&D

Al­tos Labs buys an­ti-ag­ing start­up Do­ri­an Ther­a­peu­tics

Last month
Startups
First page Previous page 12345 Next page Last page
A service from the Financial Times